{{Rsnum
|rsid=13137105
|Gene=RCHY1
|Chromosome=4
|position=75491177
|Orientation=plus
|GMAF=0.4054
|Gene_s=RCHY1
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 36.3 | 42.5 | 21.2
| HCB | 31.9 | 54.1 | 14.1
| JPT | 38.1 | 48.7 | 13.3
| YRI | 34.9 | 54.1 | 11.0
| ASW | 22.8 | 42.1 | 35.1
| CHB | 31.9 | 54.1 | 14.1
| CHD | 23.9 | 59.6 | 16.5
| GIH | 55.4 | 39.6 | 5.0
| LWK | 30.3 | 53.2 | 16.5
| MEX | 43.1 | 43.1 | 13.8
| MKK | 35.3 | 51.9 | 12.8
| TSI | 41.2 | 44.1 | 14.7
| HapMapRevision=28
}}{{PMID Auto GWAS
|PMID=22491018
|Trait=None
|Title=Genome-wide association analysis implicates the involvement of eight loci with response to tocilizumab for the treatment of rheumatoid arthritis.
|RiskAllele=
|Pval=9E-7
|OR=6.3900
|ORtxt=None
}}

{{on chip | Illumina Human 1M}}